• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. ETHISORB UNKNOWN; ABSORBABLE, SYNTHETIC PATCH

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. ETHISORB UNKNOWN; ABSORBABLE, SYNTHETIC PATCH Back to Search Results
Device Problem Appropriate Term/Code Not Available (3191)
Patient Problems Visual Impairment (2138); No Code Available (3191)
Event Type  Injury  
Manufacturer Narrative
(b)(4).To date, the device has not been returned.If the product is returned for evaluation, any further information derived from the evaluation will be submitted in a supplemental 3500a form.Attempts are being made to obtain the following information.To date no response has been provided.If further details are received at a later date a supplemental medwatch will be sent.Were the cases discussed in this article previously reported to ethicon? if yes, please provide a complaint reference number.Does the surgeon believe that ethicon product ethisorb caused and/or contributed to the adverse events described in the article? can specific patient demographics be provided for the subjects of this article? if so, please also include: patient initials, initial procedure date, pre-existing conditions, specific medical/surgical intervention per patient.Is the product code and lot number available for any of the ethicon devices used? citation: oral surg oral med oral pathol oral radiol endod 2003;95:16-22.Doi:10.1067/moe.2003.11.
 
Event Description
It was reported in a journal article that the patient underwent an orbital floor fracture reconstruction procedure on an unknown date and a patch was used.Inclusion criteria were patients between 18 and 60 years of age with maximum-size fractures of the orbital floor of 2x2 cm.Follow up was performed at preoperative, postoperative, 3 months, 4-11 months, 12-15 months, and 15-24 months intervals.The patient possibly experienced exophthalmos, enophthalmos, reduced bulbus/ motility, and or diplopia.Treatment of the events was not reported.Inflammatory reactions could be responsible for adhesions of the ocular muscles.Such adhesions could cause a reduction of bulbus motility that could also result in diplopia.Bulbus motility, diplopia, exophthalmos, and enophthalmos do not depend only on the size of an orbital floor defect or the material that was used for reconstruction.Concomitant injuries of the orbital walls or injuries of the eyeball also influence these factors.Additional information has been requested.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ETHISORB UNKNOWN
Type of Device
ABSORBABLE, SYNTHETIC PATCH
Manufacturer (Section D)
ETHICON INC.
p.o. box 151, route 22 west
somerville 08876 0151
Manufacturer (Section G)
ETHICON INC. GMBH
p.o. box 1409 d22841
norderstedt
GM  
Manufacturer Contact
darlene kyle
p.o. box 151, route 22 west
somerville 08876-0151
9082182792
MDR Report Key7116614
MDR Text Key94802607
Report Number2210968-2017-71772
Device Sequence Number1
Product Code GXQ
Combination Product (y/n)N
Reporter Country CodeAU
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,literature,study
Reporter Occupation Other
Type of Report Initial
Report Date 11/24/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/14/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Date Manufacturer Received11/24/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-